Submission Details
| 510(k) Number | K233201 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 28, 2023 |
| Decision Date | March 27, 2024 |
| Days to Decision | 181 days |
| Submission Type | Traditional |
| Review Panel | Neurology (NE) |
| Summary | Summary PDF |
K233201 is an FDA 510(k) clearance for the MIDWAY Delivery Catheter (MIDWAY 43 Delivery Catheter; MIDWAY 62 Delivery Catheter), a Catheter, Percutaneous, Neurovasculature (Class II — Special Controls, product code QJP), submitted by Penumbra, Inc. (Alameda, US). The FDA issued a Cleared decision on March 27, 2024, 181 days after receiving the submission on September 28, 2023. This device falls under the Neurology review panel. Regulated under 21 CFR 870.1250.
| 510(k) Number | K233201 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 28, 2023 |
| Decision Date | March 27, 2024 |
| Days to Decision | 181 days |
| Submission Type | Traditional |
| Review Panel | Neurology (NE) |
| Summary | Summary PDF |
| Product Code | QJP — Catheter, Percutaneous, Neurovasculature |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 870.1250 |
| Definition | To Provide Vascular Access To The Neurovasculature For Interventional Or Diagnostic Procedures |